Literature DB >> 29378796

Bacterial Periplasmic Oxidoreductases Control the Activity of Oxidized Human Antimicrobial β-Defensin 1.

J Wendler1, D Ehmann1, L Courth1, B O Schroeder2, N P Malek1, J Wehkamp3.   

Abstract

The antimicrobial peptide human β-defensin 1 (hBD1) is continuously produced by epithelial cells in many tissues. Compared to other defensins, hBD1 has only minor antibiotic activity in its native state. After reduction of its disulfide bridges, however, it becomes a potent antimicrobial agent against bacteria, while the oxidized native form (hBD1ox) shows specific activity against Gram-negative bacteria. We show that the killing mechanism of hBD1ox depends on aerobic growth conditions and bacterial enzymes. We analyzed the different activities of hBD1 using mutants of Escherichia coli lacking one or more specific proteins of their outer membrane, cytosol, or redox systems. We discovered that DsbA and DsbB are essential for the antimicrobial activity of hBD1ox but not for that of reduced hBD1 (hBD1red). Furthermore, our results strongly suggest that hBD1ox uses outer membrane protein FepA to penetrate the bacterial periplasm space. In contrast, other bacterial proteins in the outer membrane and cytosol did not modify the antimicrobial activity. Using immunogold labeling, we identified the localization of hBD1ox in the periplasmic space and partly in the outer membrane of E. coli However, in resistant mutants lacking DsbA and DsbB, hBD1ox was detected mainly in the bacterial cytosol. In summary, we discovered that hBD1ox could use FepA to enter the periplasmic space, where its activity depends on presence of DsbA and DsbB. HBD1ox concentrates in the periplasm in Gram-negative bacteria, which finally leads to bleb formation and death of the bacteria. Thus, the bacterial redox system plays an essential role in mechanisms of resistance against host-derived peptides such as hBD1.
Copyright © 2018 American Society for Microbiology.

Entities:  

Keywords:  antimicrobial peptides; defensins; hBD1; innate host defense; periplasmic oxidoreductases DsbA and DsbB; redox regulation

Mesh:

Substances:

Year:  2018        PMID: 29378796      PMCID: PMC5865016          DOI: 10.1128/IAI.00875-17

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  39 in total

Review 1.  DsbA: a protein-folding catalyst contributing to bacterial virulence.

Authors:  J Yu; J S Kroll
Journal:  Microbes Infect       Date:  1999-12       Impact factor: 2.700

2.  Antimicrobial peptides of multicellular organisms.

Authors:  Michael Zasloff
Journal:  Nature       Date:  2002-01-24       Impact factor: 49.962

Review 3.  DSB proteins and bacterial pathogenicity.

Authors:  Begoña Heras; Stephen R Shouldice; Makrina Totsika; Martin J Scanlon; Mark A Schembri; Jennifer L Martin
Journal:  Nat Rev Microbiol       Date:  2009-02-09       Impact factor: 60.633

4.  Immunology: Peptide gets in shape for self-defence.

Authors:  Robert I Lehrer
Journal:  Nature       Date:  2011-01-20       Impact factor: 49.962

Review 5.  Interactions between the host innate immune system and microbes in inflammatory bowel disease.

Authors:  Clara Abraham; Ruslan Medzhitov
Journal:  Gastroenterology       Date:  2011-05       Impact factor: 22.682

6.  Reduction of disulphide bonds unmasks potent antimicrobial activity of human β-defensin 1.

Authors:  Bjoern O Schroeder; Zhihong Wu; Sabine Nuding; Sandra Groscurth; Moritz Marcinowski; Julia Beisner; Johannes Buchner; Martin Schaller; Eduard F Stange; Jan Wehkamp
Journal:  Nature       Date:  2011-01-20       Impact factor: 49.962

Review 7.  Surface proteins of gram-positive bacteria and mechanisms of their targeting to the cell wall envelope.

Authors:  W W Navarre; O Schneewind
Journal:  Microbiol Mol Biol Rev       Date:  1999-03       Impact factor: 11.056

8.  Role of F1C fimbriae, flagella, and secreted bacterial components in the inhibitory effect of probiotic Escherichia coli Nissle 1917 on atypical enteropathogenic E. coli infection.

Authors:  Sylvia Kleta; Marcel Nordhoff; Karsten Tedin; Lothar H Wieler; Rafal Kolenda; Sibylle Oswald; Tobias A Oelschlaeger; Wilfried Bleiss; Peter Schierack
Journal:  Infect Immun       Date:  2014-02-18       Impact factor: 3.441

9.  Identification of a protein required for disulfide bond formation in vivo.

Authors:  J C Bardwell; K McGovern; J Beckwith
Journal:  Cell       Date:  1991-11-01       Impact factor: 41.582

10.  The disulphide isomerase DsbC cooperates with the oxidase DsbA in a DsbD-independent manner.

Authors:  Didier Vertommen; Matthieu Depuydt; Jonathan Pan; Pauline Leverrier; Laurent Knoops; Jean-Pierre Szikora; Joris Messens; James C A Bardwell; Jean-Francois Collet
Journal:  Mol Microbiol       Date:  2007-11-25       Impact factor: 3.501

View more
  4 in total

1.  Proteolytic Degradation of reduced Human Beta Defensin 1 generates a Novel Antibiotic Octapeptide.

Authors:  Judith Wendler; Bjoern O Schroeder; Dirk Ehmann; Louis Koeninger; Daniela Mailänder-Sánchez; Christina Lemberg; Stephanie Wanner; Martin Schaller; Eduard F Stange; Nisar P Malek; Christopher Weidenmaier; Salomé LeibundGut-Landmann; Jan Wehkamp
Journal:  Sci Rep       Date:  2019-03-06       Impact factor: 4.379

Review 2.  Role of Metabolic Endotoxemia in Systemic Inflammation and Potential Interventions.

Authors:  Shireen Mohammad; Christoph Thiemermann
Journal:  Front Immunol       Date:  2021-01-11       Impact factor: 7.561

3.  Porcine Beta-Defensin 2 Provides Protection Against Bacterial Infection by a Direct Bactericidal Activity and Alleviates Inflammation via Interference With the TLR4/NF-κB Pathway.

Authors:  Chao Huang; Xi Yang; Jing Huang; Xiao Liu; Xiaoyu Yang; Hui Jin; Qi Huang; Lu Li; Rui Zhou
Journal:  Front Immunol       Date:  2019-07-18       Impact factor: 7.561

Review 4.  Redox Active Antimicrobial Peptides in Controlling Growth of Microorganisms at Body Barriers.

Authors:  Piotr Brzoza; Urszula Godlewska; Arkadiusz Borek; Agnieszka Morytko; Aneta Zegar; Patrycja Kwiecinska; Brian A Zabel; Artur Osyczka; Mateusz Kwitniewski; Joanna Cichy
Journal:  Antioxidants (Basel)       Date:  2021-03-13
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.